Semaglutide injection for the treatment of adults with type 2 diabetes.

Published in: Expert review of clinical pharmacology (2020)

This section discusses the position of semaglutide and the risks and benefits versus other once weekly GLP-1RAs and finally the development of an oral version of semaglutide, which has recently been approved in the United States.

Keyphrases

human health
ultrasound guided

psychometric properties
risk assessment

combination therapy
wild type

smoking cessation